
Walter E. Webb
Examiner (ID: 8444, Phone: (571)270-3287 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 4133, 1612 |
| Total Applications | 1244 |
| Issued Applications | 565 |
| Pending Applications | 114 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5748426
[patent_doc_number] => 20060111358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Treatment of aml'
[patent_app_type] => utility
[patent_app_number] => 10/530452
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5955
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111358.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530452
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530452 | Treatment of aml | Oct 6, 2003 | Abandoned |
Array
(
[id] => 5799156
[patent_doc_number] => 20060034780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Dental compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/528828
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4934
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528828 | Dental compositions and methods | Sep 22, 2003 | Abandoned |
Array
(
[id] => 5866009
[patent_doc_number] => 20060100140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia'
[patent_app_type] => utility
[patent_app_number] => 10/527553
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11863
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527553 | Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia | Sep 9, 2003 | Abandoned |
Array
(
[id] => 6977369
[patent_doc_number] => 20050287085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Composition for improving the physico-chemical properties of apatite-based materials, uses thereof and method using same'
[patent_app_type] => utility
[patent_app_number] => 10/526581
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4120
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526581
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526581 | Composition for improving the physico-chemical properties of apatite-based materials, uses thereof and method using same | Sep 3, 2003 | Abandoned |
Array
(
[id] => 5720382
[patent_doc_number] => 20060073156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract'
[patent_app_type] => utility
[patent_app_number] => 10/526404
[patent_app_country] => US
[patent_app_date] => 2003-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1615
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073156.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526404 | Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract | Aug 31, 2003 | Abandoned |
Array
(
[id] => 6952953
[patent_doc_number] => 20050228048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Stable eye drops containing latanoprost as the active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/524996
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3097
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20050228048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524996
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524996 | Stable eye drops containing latanoprost as the active ingredient | Aug 21, 2003 | Abandoned |
Array
(
[id] => 5786873
[patent_doc_number] => 20060205809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease'
[patent_app_type] => utility
[patent_app_number] => 10/525500
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3738
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525500 | Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease | Aug 19, 2003 | Abandoned |
Array
(
[id] => 7168507
[patent_doc_number] => 20050202049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Retinoid-containing preparations'
[patent_app_type] => utility
[patent_app_number] => 10/515636
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3946
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515636
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515636 | Retinoid-containing preparations | Jul 15, 2003 | Abandoned |
Array
(
[id] => 5040257
[patent_doc_number] => 20070092539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Method of preparing an aqueous meloxicam solution and aqueous solution thus produced'
[patent_app_type] => utility
[patent_app_number] => 10/564271
[patent_app_country] => US
[patent_app_date] => 2003-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1763
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564271 | Method of preparing an aqueous meloxicam solution and aqueous solution thus produced | Jul 9, 2003 | Abandoned |
Array
(
[id] => 5743670
[patent_doc_number] => 20060089395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Nf-kb activation inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/516294
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 70632
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516294 | Nf-kb activation inhibitors | Jun 4, 2003 | Abandoned |
Array
(
[id] => 5632332
[patent_doc_number] => 20060148802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Use of compounds that stimulate cgmp'
[patent_app_type] => utility
[patent_app_number] => 10/516778
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3691
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516778 | Use of compounds that stimulate cgmp | May 29, 2003 | Abandoned |
Array
(
[id] => 5851764
[patent_doc_number] => 20060234955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders'
[patent_app_type] => utility
[patent_app_number] => 10/515260
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12910
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234955.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515260 | Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders | May 27, 2003 | Abandoned |
Array
(
[id] => 5648496
[patent_doc_number] => 20060134228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Medicine for prevention of and treatment for amyloidosis'
[patent_app_type] => utility
[patent_app_number] => 10/514335
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3958
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514335
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514335 | Medicine for prevention of and treatment for amyloidosis | May 12, 2003 | Abandoned |
Array
(
[id] => 5808309
[patent_doc_number] => 20060094664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation'
[patent_app_type] => utility
[patent_app_number] => 10/512856
[patent_app_country] => US
[patent_app_date] => 2003-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3191
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094664.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512856 | Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation | May 8, 2003 | Abandoned |
Array
(
[id] => 7193586
[patent_doc_number] => 20050163853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Novel biomaterials their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 10/511075
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12606
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20050163853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511075 | Novel biomaterials their preparation and use | Apr 16, 2003 | Abandoned |
Array
(
[id] => 5715192
[patent_doc_number] => 20060078555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Intraventricular hemorrhage thrombolysis'
[patent_app_type] => utility
[patent_app_number] => 10/509694
[patent_app_country] => US
[patent_app_date] => 2003-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17068
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509694 | Intraventricular hemorrhage thrombolysis | Mar 28, 2003 | Abandoned |
Array
(
[id] => 7142995
[patent_doc_number] => 20050118269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'External preparation for wounds'
[patent_app_type] => utility
[patent_app_number] => 10/507522
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6143
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507522 | External preparation for wounds | Mar 11, 2003 | Issued |
Array
(
[id] => 5894322
[patent_doc_number] => 20060002861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist'
[patent_app_type] => utility
[patent_app_number] => 10/502966
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11957
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502966
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502966 | Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist | Feb 3, 2003 | Abandoned |
Array
(
[id] => 6911787
[patent_doc_number] => 20050175545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist'
[patent_app_type] => utility
[patent_app_number] => 10/503540
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17596
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503540
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503540 | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist | Feb 3, 2003 | Abandoned |
Array
(
[id] => 7098488
[patent_doc_number] => 20050130947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Formulations for inhalation'
[patent_app_type] => utility
[patent_app_number] => 10/503396
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9905
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503396 | Formulations for inhalation | Feb 3, 2003 | Abandoned |